Yugong Biotechnology
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- Undisclosed
Investors
- 2
About Yugong Biotechnology
Based in Lianyunganag, China, and founded in 2021, Yugong Biotechnology operates as a nucleic acid raw material manufacturer, committed to providing tools, enzymes and raw materials for China's biomedical industry. The company has built a 4500 square meters of R & D, production base, including a 500 square meters of clean production workshop. Yugong Biotechnology has set up a subsidiary. The company is engaged in molecular diagnosis and nucleic acid drug production raw material enzymes, life science tool enzymes and related reagents research and development and production. Yugong Biotechnology has more than 100 kinds of terminal products in 10 series, including restriction enzyme, PCR, isothermal amplification, reverse transcription, fluorescence quantitative PCR, in vitro transcription, modified cloning, and buffer solution instant granules.
Who invested in Yugong Biotechnology
2 investors across 2 rounds
See all investors in Yugong Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yugong Biotechnology
Who invested in Yugong Biotechnology?
Yugong Biotechnology has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yugong Biotechnology raised?
Yugong Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Yugong Biotechnology last raise money?
Yugong Biotechnology's most recent round on record is a Series A, in Feb 2023.
What does Yugong Biotechnology do?
Based in Lianyunganag, China, and founded in 2021, Yugong Biotechnology operates as a nucleic acid raw material manufacturer, committed to providing tools, enzymes and raw materials for China's biomedical industry.
Where is Yugong Biotechnology headquartered?
Yugong Biotechnology is headquartered in Lianyungang, China.
Which VCs invest in companies like Yugong Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Yugong Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Yugong Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.